Methods of treating chronic disorders with complement inhibitors
US-11712460-B2 · Aug 1, 2023 · US
This page is not indexed by search engines while we improve data quality.
Apellis Pharmaceuticals Inc — Physics
Apellis Pharmaceuticals Inc holds 28 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Apellis Pharmaceuticals Inc |
| Technology | Physics |
| Patents in slice | 28 |
| Recent patents in slice | 1 |
| First year | 2016 |
| Last year | 2023 |
Representative patents
Notable publications linking Apellis Pharmaceuticals Inc to Physics.
Methods of treating chronic disorders with complement inhibitors
US-11712460-B2 · Aug 1, 2023 · US
Methods of treating chronic disorders with complement inhibitors
US-11712460-B2 · Aug 1, 2023 · US
Methods of treating chronic disorders with complement inhibitors
US-11712460-B2 · Aug 1, 2023 · US
Methods of treating chronic disorders with complement inhibitors
US-11712460-B2 · Aug 1, 2023 · US
Recent filings
Latest patents from Apellis Pharmaceuticals Inc in Physics.
Methods of treating chronic disorders with complement inhibitors
US-11712460-B2 · Aug 1, 2023 · US
Methods of treating chronic disorders with complement inhibitors
US-11712460-B2 · Aug 1, 2023 · US
Methods of treating chronic disorders with complement inhibitors
US-11712460-B2 · Aug 1, 2023 · US
Methods of treating chronic disorders with complement inhibitors
US-11712460-B2 · Aug 1, 2023 · US
Methods of treating chronic disorders with complement inhibitors
US-11712460-B2 · Aug 1, 2023 · US
Related pages
Navigate to parent entity pages.